Epidural plus general anesthesia may cut muscle relaxant use in stomach cancer surgery

NCT ID NCT05907811

Completed Knowledge-focused Sponsor: Yuzuncu Yil University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 60 people having stomach cancer surgery to see if adding an epidural to general anesthesia changes how much muscle relaxant is needed and how fast it wears off. Half got general anesthesia alone, half got general anesthesia plus a thoracic epidural. Researchers measured muscle recovery time and pain levels. The goal was to find the best way to manage anesthesia for these surgeries.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: neuromuscular blocker (rocuronium)
What this could lead to: If successful, this could help anesthesiologists choose the best anesthesia method to reduce muscle relaxant use and improve recovery after gastric cancer surgery.
What could go wrong: This is a small, single-center study with only 60 patients. Results may not apply to other surgeries or hospitals. The study is already completed, so no new treatments are being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC CANCER THORACAL EPIDURAL BLOCK THORACIC EPIDURAL ANALGESIA

Contacts and locations

Locations

Arzu Esen Tekeli

Van, Turkey, 65100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.